Related Experiment Video
Updated: Mar 12, 2026

Digital PCR for Quantifying Circulating MicroRNAs in Acute Myocardial Infarction and Cardiovascular Disease
Published on: July 3, 2018
The Values of Coronary Circulating miRNAs in Patients with Atrial Fibrillation
Guiyu Xu1, Yuxia Cui1, Zhenghua Jia2
1The Department of Cardiology, Capital Medical University Affiliated Beijing Shijitan Hospital, Beijing, China.
Abstract:
The mechanism of miRNA regulation in atrial fibrillation (AF) occurrence and development is still unclear, especially, the regulating values of coronary circulating miRNAs has not been reported. Based on our AF radiofrequency ablation clinical practice and previous miRNA study, we proposed a hypothesis that the coronary circulating miRNA might much better reflect the regulating state and metabolic level of myocardial miRNA in AF patient. To investigate the regulating values of coronary circulation miRNA, 90 AF patients were selected and compared with 90 healthy subjects, the changes of coronary circulating miRNA differential expression profile in the whole genome were observed in this study. We found out that compared with autologous peripheral blood (PB), 6 miRNAs were upregulated and 8 miRNA downregulated in AF patients' coronary sinus blood (CSB) significantly, especially, the expression of miR-1266, miR-4279 and miR-4666a-3p were obviously increased. Compared with normal donors' peripheral blood, 16 miRNAs were upregulated and 24 miRNAs downregulated dramatically in patients' peripheral blood, among them, the miR-3171 decreased, but miR-892a and miR-3149 increased significantly from the early to end stages of AF. Our results indicated that the coronary circulating miRNA can really reflect the regulating values of miRNA in AF patient; the level of miRNA change in 3 types of AF may reflect the severity of AF clinical and pathophysiological advance; The miR-892a, miR-3171 and miR-3149 may be used as biomarkers for earlier diagnosis, while miR-1266, miR-4279 and miR-4666a-3p may serve as potential intervening targets for AF patient in future.
Insights
Coronary circulating microRNAs (miRNAs) reflect atrial fibrillation (AF) regulation. Specific miRNAs in coronary sinus blood and peripheral blood may serve as early diagnostic biomarkers or therapeutic targets for AF patients.
Area of Science:
- Cardiology
- Molecular Biology
- Biochemistry
Background:
- The precise mechanism of microRNA (miRNA) regulation in atrial fibrillation (AF) remains largely unknown.
- The role of coronary circulating miRNAs in reflecting myocardial miRNA status in AF patients has not been previously investigated.
Purpose of the Study:
- To investigate the diagnostic and prognostic value of coronary circulating miRNAs in AF.
- To explore the differential expression profile of miRNAs in coronary sinus blood (CSB) and peripheral blood (PB) of AF patients compared to healthy controls.
Main Methods:
- Analysis of miRNA expression profiles in CSB and PB from 90 AF patients and 90 healthy subjects.
- Comparison of miRNA levels between AF patients and controls using whole-genome analysis.
Main Results:
- In AF patients, 6 miRNAs were upregulated and 8 downregulated in CSB compared to autologous PB. Notably, miR-1266, miR-4279, and miR-4666a-3p were significantly increased.
- In PB, 16 miRNAs were upregulated and 24 downregulated compared to normal donors. miR-3171 decreased, while miR-892a and miR-3149 increased significantly with AF progression.
Conclusions:
- Coronary circulating miRNAs accurately reflect the regulatory status of myocardial miRNAs in AF.
- Altered miRNA levels in AF patients correlate with disease severity and may serve as potential biomarkers for early diagnosis (miR-892a, miR-3171, miR-3149) and therapeutic targets (miR-1266, miR-4279, miR-4666a-3p).
More Related Videos
08:10Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation
Published on: July 20, 2022
09:48Fast and Simplified Method for High Through-put Isolation of miRNA from Highly Purified High Density Lipoprotein
Published on: July 27, 2016